This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan paraffin-section IHC around nuclear DMRT1 staining in a subset of spermatogonia (HPA tissue IHC). Use testis as a positive control (HPA tissue IHC) and interpret staining with the reported off-target binding in mind (HPA tissue IHC).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Nuclear staining in a subset of spermatogonia (HPA tissue IHC) | |
| Staining pattern | A subset of spermatogonia shows nuclear staining (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6 HIER, heat-mediated (datasheet RP1083) | |
| Positive control | Testis | |
| Negative control | Adipose tissue+4 more · see all |
| Fixation | Keep fixation consistent across sections. (standard IHC practice; not target-specific) | |
| Caveat | Presumed off-target staining can confound interpretation (HPA tissue IHC) | |
| Regulation | Testis-enriched RNA expression (HPA tissue RNA) | |
| Isoform / epitope | 3 isoforms; verify epitope coverage (UniProt) |
The catalog antibody protocol is paired with one published chromogenic DMRT1 IHC protocol (PMC6529513).
| Sample | Paraffin-embedded rat testis tissue; fixative not specified (datasheet RP1083) |
| Fixation | Image fixative and duration unreported (datasheet RP1083); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: Citrate pH 6, 20 min (datasheet RP1083) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet RP1083) |
| Primary antibody | Rabbit anti-DMRT1, 0.5-1μg/ml (datasheet RP1083) |
| Primary incubation | Overnight at 4 °C (datasheet RP1083) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet RP1083) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | DMRT1-positive staining in preleptotene spermatocytes of testis (HPA tissue IHC: High). HPA tissue profile: Nuclear expression in a subset spermatogonia. No signal in the no-primary control. |
DMRT1 is a nuclear transcription factor with no transmembrane segment (UniProt Q9Y5R6: subcellular location, topology). In testis IHC, expect nuclear staining in a subset of spermatogonia; HPA also records high staining in preleptotene spermatocytes (HPA: tissue profile, testis). HPA rates its IHC evidence Enhanced, while noting medium consistency with RNA data and presumed off-target staining that was disregarded (HPA: reliability).
| Distinct nuclear staining in selected germ cells of a testis section, with strong signal in preleptotene spermatocytes. | This fits the reported nuclear pattern in a subset of spermatogonia and the High level recorded for preleptotene spermatocytes (HPA: tissue profile, testis). Score the stained cells and their compartment together; signal elsewhere does not establish a DMRT1-positive result. |
| Predominantly cytoplasmic, membranous, or extracellular staining, without a convincing nuclear component. | The compartment disagrees with DMRT1's nuclear location and lack of a transmembrane segment (UniProt Q9Y5R6: subcellular location, topology). Treat it as a possible staining artefact; review morphology and controls before assigning target expression. |
| Strong staining in cells outside the expected testis germ-cell population. | Unexpected cell staining may reflect antibody cross-reactivity or endogenous detection activity (general IHC practice). HPA reports presumed off-target binding that was disregarded during assessment (HPA: reliability). Check whether the signal is nuclear and compare matched detection controls before interpreting it as DMRT1. |
| Broad, weak colour across nuclei, cytoplasm, and tissue spaces. | Diffuse signal obscures the selective nuclear pattern reported for testis (HPA: tissue profile). It may arise from background in the staining or detection workflow (general IHC practice). Evaluate the negative and detection controls before scoring faint nuclei as positive. |
| No convincing nuclear signal in the expected cells of a testis section. | An absent positive pattern conflicts with HPA's reported testis staining, including its High preleptotene-spermatocyte entry (HPA: tissue profile, testis). First confirm that the relevant cells are present; then investigate the IHC workflow. The supplied sources do not establish DMRT1-specific fixation sensitivity. |
| Target compartment | DMRT1 is nuclear and has no transmembrane segment (UniProt Q9Y5R6: subcellular location, topology). Nuclear location should anchor interpretation; membrane staining alone does not fit the annotated protein. |
| Strength of IHC evidence | HPA rates antibody HPA027850 Enhanced, but describes only medium consistency between staining and RNA data and notes disregarded presumed off-target binding (HPA: antibody validation, reliability). Interpret unexpected cells cautiously. |
| Molecular variation | UniProt lists 3 isoforms and phosphoserine at residue 339 (UniProt Q9Y5R6: isoforms, modified residues). The supplied sources give no epitope map or evidence that either feature changes IHC staining. |
| IF/ICC: is its staining pattern established? | A nuclear pattern is expected from UniProt (UniProt Q9Y5R6: subcellular location). HPA supplies no ICC-IF images or main location for DMRT1, so it does not independently establish an IF/ICC pattern (HPA: subcellular record). |
| Situation | Likely cause | Next action |
|---|---|---|
| Testis section has no nuclear staining in the expected germ cells. | Relevant cells may be absent from the section, or the IHC workflow may have failed (general IHC practice). HPA reports testis-positive cells (HPA: tissue profile). | Inspect morphology for the expected cells, then review antigen retrieval, antibody incubation, detection, and controls as general IHC workflow checks. Do not infer a DMRT1-specific fixation effect from the supplied sources. |
| Signal is strong but mainly cytoplasmic. | That compartment conflicts with the nuclear annotation for DMRT1 (UniProt Q9Y5R6: subcellular location). Background or nonspecific binding is possible (general IHC practice). | Compare a matched negative control and the testis nuclear reference pattern (HPA: tissue profile). Score cytoplasmic signal separately from any convincing nuclear staining. |
| Many unexpected cells stain in a testis section. | Cross-reactivity or endogenous detection activity may contribute (general IHC practice); HPA also notes presumed off-target binding in its IHC assessment (HPA: reliability). | Check cell identity, nuclear localisation, and detection controls. Limit a DMRT1-positive call to a pattern supported by the testis profile (HPA: tissue profile). |
| A comparison section shows staining in adipocytes or adrenal glandular cells. | HPA records DMRT1 as Not detected in those specific cell types (HPA: adipose tissue, adrenal gland). The discrepancy warrants investigation; it does not identify its cause. | Review the exact stained cell type and compartment, then compare antibody and detection controls (general IHC practice). Avoid treating either entire tissue as universally negative. |
| Diffuse brown background makes nuclear boundaries hard to judge. | Background from blocking, washes, or detection can obscure cellular localisation (general IHC practice). It cannot be assigned to DMRT1 from colour alone. | Review blocking, wash, detection, and counterstain conditions using appropriate controls (general IHC practice). Score only nuclei that remain distinct from surrounding background. |
| A few isolated dark deposits appear without a consistent cell pattern. | Deposits may reflect detection artefact rather than the selective nuclear testis pattern (general IHC practice; HPA: tissue profile). | Compare adjacent cells and control sections, and require reproducible nuclear staining in the expected cell population before calling a positive result (general IHC practice; HPA: tissue profile). |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — Medium consistency between antibody staining and RNA expression data. Presumed off target binding observed and disregarded.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | Preleptotene spermatocytes | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
Troubleshoot DMRT1 staining by checking nuclear localisation, testis cell populations, and assay controls before interpreting signal intensity.
The IHC-validated anti-DMRT1 antibody has paraffin-section images from rat, mouse and human testis (RP1083 IHC image captions); IF/ICC data are unreported (RP1083 catalog applications).
RP1083 is the sole card and shows rat testis paraffin-section IHC (RP1083 card figure caption). Additional captions show mouse and human testis paraffin-section IHC (RP1083 IHC image captions).
Which to pick: Choose RP1083 for paraffin-section IHC; its figure documents citrate retrieval at pH 6 for 20 minutes and primary antibody at 1 μg/ml (RP1083 card figure caption). For cross-species work, RP1083 lists human, mouse and rat reactivity; it is rabbit-hosted, with clonality unreported (RP1083 catalog). No IF/ICC-validated SKU is listed (RP1083 catalog applications); the IHC caption identifies paraffin sections but does not report the fixative (RP1083 card figure caption).